What is Surgical Science Sweden AB Earnings Yield (Joel Greenblatt) %?
Surgical Science Sweden AB's Enterprise Value for the quarter that ended in Dec. 2023 was kr8,717.9 Mil.
Surgical Science Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr268.9 Mil. Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 3.08%.
The historical rank and industry rank for Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
OSTO:SUS'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4.08 Med: 0.51 Max: 4.69
Current: 3.7
During the past 9 years, the highest Earnings Yield (Joel Greenblatt) of Surgical Science Sweden AB was 4.69%. The lowest was -4.08%. And the median was 0.51%.
OSTO:SUS's Earnings Yield (Joel Greenblatt) % is ranked better than 58.59% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 2.54
vs OSTO:SUS: 3.70
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Surgical Science Sweden AB Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Surgical Science Sweden AB Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) %
For the Health Information Services subindustry, Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % falls into.
Surgical Science Sweden AB Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Surgical Science Sweden ABs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
Surgical Science Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr268.9 Mil.
Surgical Science Sweden AB (OSTO:SUS) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Surgical Science Sweden AB Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgical Science Sweden AB (OSTO:SUS) Business Description
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:SUS has been successfully added to your 